Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting intradialytic exercise intolerance in maintenance hemodialysis patients: an interpretable machine learning approach integrating functional assessments.

Renal failure·2026
Same author

Identification of a novel SXT/R391 integrative and conjugative element harboring <i>bla</i> <sub>NDM-1</sub> in a clinical <i>Providencia huaxiensis</i> isolate.

Frontiers in microbiology·2026
Same author

Prophylactic Proton Pump Inhibitors in Critically Ill Patients Undergoing Invasive Ventilation: A Systematic Review and Meta-Analysis of Randomized Trials.

Critical care research and practice·2026
Same author

Cysteine protease as a novel serodiagnostic marker for Spirometra mansoni infection in cats.

Veterinary parasitology·2026
Same author

Aztreonam-avibactam for Carbapenem-resistant gram-negative infections: Mechanisms, clinical efficacy, the challenge of resistance and susceptibility testing.

International journal of antimicrobial agents·2026
Same author

Retraction: Tetrahydrocurcumin induces mesenchymalepithelial transition and suppresses angiogenesis by targeting HIF1α and autophagy in human osteosarcoma.

Oncotarget·2026

Related Experiment Video

Updated: Jul 8, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Enhanced Nursing Intervention, Glycemic Variability, And In-Hospital Outcomes In Type 2 Diabetes Mellitus: A

Haiyan Ye1, Yinpei Ma2, Lixin Yan2

  • 1Urology and Metabolic Rehabilitation Center, Beijing Rehabilitation Hospital Affiliated to Capital Medical University; yehaiyan01@hotmail.com.

Journal of Visualized Experiments : Jove
|July 6, 2026
PubMed
Summary

Enhanced nursing care significantly reduces glycemic variability and improves hospitalization outcomes for type 2 diabetes mellitus (T2DM) patients. This intervention leads to better blood sugar control and shorter hospital stays.

Related Experiment Videos

Last Updated: Jul 8, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Area of Science:

  • Endocrinology
  • Nursing Science
  • Health Services Research

Background:

  • Type 2 diabetes mellitus (T2DM) management requires continuous monitoring and patient engagement.
  • Glycemic variability and suboptimal hospitalization outcomes are significant challenges in T2DM care.
  • Enhanced nursing interventions may offer a solution to improve patient outcomes.

Purpose of the Study:

  • To investigate the association between enhanced nursing intervention and glycemic variability in hospitalized T2DM patients.
  • To evaluate the impact of enhanced nursing on short-term hospitalization outcomes.
  • To identify enhanced nursing as a potential protective factor for T2DM management.

Main Methods:

  • Retrospective cohort study of hospitalized T2DM patients (December 2022 - December 2025).
  • Propensity score matching (1:1) for 100 patients (50 enhanced care, 50 routine care).
  • Enhanced nursing included diet, exercise, psychological support, self-management education, and continuous glucose monitoring.

Main Results:

  • Enhanced nursing group showed significantly lower glycemic variability (p < 0.05).
  • Reduced fasting and postprandial glucose levels observed in the enhanced nursing group (p < 0.05).
  • Shorter length of stay, lower 30-day readmission rate (2.0% vs 14.0%), and fewer hypoglycemic events (6.0% vs 24.0%) in the enhanced group.

Conclusions:

  • Enhanced nursing intervention is linked to improved glycemic stability in T2DM patients.
  • This intervention is associated with better short-term hospitalization outcomes, including reduced readmissions and fewer complications.
  • Enhanced nursing represents an independent protective factor for managing T2DM during hospitalization.